A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations
Clinical trial NCT02596100 · COMPLETED
Trial details
- NCT number
- NCT02596100
- Sponsor
- Portola Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2015-11-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.